BioPlus Acquisition Corp.
BioPlus Acquisition Corp. BIOS Peers
See (BIOS) competitors and their performances in Stock Market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIOS | $10.80 | -0.05% | 209.07M | 51.40 | $0.21 | N/A |
| CCIV | $24.25 | +5.90% | 44.39B | N/A | N/A | N/A |
| SYM | $28.00 | +4.87% | 16.51B | -350.00 | -$0.08 | N/A |
| PSACU | $17.08 | +0.35% | 12.00B | -108.79 | -$0.16 | N/A |
| RTPY | $9.91 | -0.30% | 11.62B | N/A | N/A | N/A |
| LVRAW | $0.04 | N/A | 11.53B | N/A | N/A | N/A |
| CMLFU | $13.00 | -4.55% | 10.31B | -1444.44 | -$0.01 | N/A |
| PSAC | $13.78 | -0.36% | 9.68B | N/A | N/A | N/A |
| GRSVU | $11.39 | +3.36% | 6.81B | N/A | N/A | N/A |
| APSG | $7.39 | N/A | 6.33B | 36.95 | $0.20 | N/A |
Stock Comparison
BIOS vs CCIV Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CCIV has a market cap of 44.39B. Regarding current trading prices, BIOS is priced at $10.80, while CCIV trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CCIV's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to CCIV's ROE of -0.69%. Regarding short-term risk, BIOS is less volatile compared to CCIV. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SYM Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SYM has a market cap of 16.51B. Regarding current trading prices, BIOS is priced at $10.80, while SYM trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SYM's P/E ratio is -350.00. In terms of profitability, BIOS's ROE is +0.02%, compared to SYM's ROE of -0.05%. Regarding short-term risk, BIOS is less volatile compared to SYM. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs PSACU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, PSACU has a market cap of 12.00B. Regarding current trading prices, BIOS is priced at $10.80, while PSACU trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas PSACU's P/E ratio is -108.79. In terms of profitability, BIOS's ROE is +0.02%, compared to PSACU's ROE of -0.42%. Regarding short-term risk, BIOS is less volatile compared to PSACU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs RTPY Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, RTPY has a market cap of 11.62B. Regarding current trading prices, BIOS is priced at $10.80, while RTPY trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas RTPY's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to RTPY's ROE of -0.73%. Regarding short-term risk, BIOS is less volatile compared to RTPY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs LVRAW Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, LVRAW has a market cap of 11.53B. Regarding current trading prices, BIOS is priced at $10.80, while LVRAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas LVRAW's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to LVRAW's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to LVRAW. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs CMLFU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CMLFU has a market cap of 10.31B. Regarding current trading prices, BIOS is priced at $10.80, while CMLFU trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CMLFU's P/E ratio is -1444.44. In terms of profitability, BIOS's ROE is +0.02%, compared to CMLFU's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to CMLFU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs PSAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, PSAC has a market cap of 9.68B. Regarding current trading prices, BIOS is priced at $10.80, while PSAC trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas PSAC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to PSAC's ROE of -0.42%. Regarding short-term risk, BIOS is less volatile compared to PSAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs GRSVU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, GRSVU has a market cap of 6.81B. Regarding current trading prices, BIOS is priced at $10.80, while GRSVU trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas GRSVU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to GRSVU's ROE of +0.00%. Regarding short-term risk, BIOS is more volatile compared to GRSVU. This indicates potentially higher risk in terms of short-term price fluctuations for BIOS.
BIOS vs APSG Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, APSG has a market cap of 6.33B. Regarding current trading prices, BIOS is priced at $10.80, while APSG trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas APSG's P/E ratio is 36.95. In terms of profitability, BIOS's ROE is +0.02%, compared to APSG's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to APSG. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs RTP Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, RTP has a market cap of 6.30B. Regarding current trading prices, BIOS is priced at $10.80, while RTP trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas RTP's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to RTP's ROE of -0.80%. Regarding short-term risk, BIOS is less volatile compared to RTP. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DGNR Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DGNR has a market cap of 5.79B. Regarding current trading prices, BIOS is priced at $10.80, while DGNR trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DGNR's P/E ratio is -308.67. In terms of profitability, BIOS's ROE is +0.02%, compared to DGNR's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to DGNR. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs VTIQ Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, VTIQ has a market cap of 5.58B. Regarding current trading prices, BIOS is priced at $10.80, while VTIQ trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas VTIQ's P/E ratio is 91.50. In terms of profitability, BIOS's ROE is +0.02%, compared to VTIQ's ROE of +472.81%. Regarding short-term risk, BIOS is more volatile compared to VTIQ. This indicates potentially higher risk in terms of short-term price fluctuations for BIOS.
BIOS vs VTIQU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, VTIQU has a market cap of 5.58B. Regarding current trading prices, BIOS is priced at $10.80, while VTIQU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas VTIQU's P/E ratio is 100.60. In terms of profitability, BIOS's ROE is +0.02%, compared to VTIQU's ROE of +472.81%. Regarding short-term risk, BIOS is more volatile compared to VTIQU. This indicates potentially higher risk in terms of short-term price fluctuations for BIOS.
BIOS vs VACQ Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, VACQ has a market cap of 5.53B. Regarding current trading prices, BIOS is priced at $10.80, while VACQ trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas VACQ's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to VACQ's ROE of -0.59%. Regarding short-term risk, BIOS is less volatile compared to VACQ. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SVFC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SVFC has a market cap of 5.06B. Regarding current trading prices, BIOS is priced at $10.80, while SVFC trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SVFC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SVFC's ROE of -0.02%. Regarding short-term risk, BIOS is less volatile compared to SVFC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs VGAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, VGAC has a market cap of 5.03B. Regarding current trading prices, BIOS is priced at $10.80, while VGAC trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas VGAC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to VGAC's ROE of -1.65%. Regarding short-term risk, BIOS is less volatile compared to VGAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs CMLT Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CMLT has a market cap of 4.25B. Regarding current trading prices, BIOS is priced at $10.80, while CMLT trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CMLT's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to CMLT's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to CMLT. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs GHVI Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, GHVI has a market cap of 4.21B. Regarding current trading prices, BIOS is priced at $10.80, while GHVI trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas GHVI's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to GHVI's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to GHVI. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs KVSB Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, KVSB has a market cap of 4.16B. Regarding current trading prices, BIOS is priced at $10.80, while KVSB trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas KVSB's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to KVSB's ROE of -0.20%. Regarding short-term risk, BIOS is less volatile compared to KVSB. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FTOCU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FTOCU has a market cap of 4.13B. Regarding current trading prices, BIOS is priced at $10.80, while FTOCU trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FTOCU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FTOCU's ROE of +0.16%. Regarding short-term risk, BIOS is less volatile compared to FTOCU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs THCBU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, THCBU has a market cap of 3.88B. Regarding current trading prices, BIOS is priced at $10.80, while THCBU trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas THCBU's P/E ratio is -101.87. In terms of profitability, BIOS's ROE is +0.02%, compared to THCBU's ROE of +0.28%. Regarding short-term risk, BIOS is less volatile compared to THCBU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs CLII Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CLII has a market cap of 3.81B. Regarding current trading prices, BIOS is priced at $10.80, while CLII trades at $14.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CLII's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to CLII's ROE of +0.71%. Regarding short-term risk, BIOS is less volatile compared to CLII. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs GRNV Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, GRNV has a market cap of 3.79B. Regarding current trading prices, BIOS is priced at $10.80, while GRNV trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas GRNV's P/E ratio is -59.68. In terms of profitability, BIOS's ROE is +0.02%, compared to GRNV's ROE of -101981.32%. Regarding short-term risk, BIOS is less volatile compared to GRNV. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FRX Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FRX has a market cap of 3.75B. Regarding current trading prices, BIOS is priced at $10.80, while FRX trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FRX's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FRX's ROE of -0.34%. Regarding short-term risk, BIOS is less volatile compared to FRX. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs HOLUU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, HOLUU has a market cap of 3.65B. Regarding current trading prices, BIOS is priced at $10.80, while HOLUU trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas HOLUU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to HOLUU's ROE of -0.13%. Regarding short-term risk, BIOS is less volatile compared to HOLUU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SSPK Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SSPK has a market cap of 3.38B. Regarding current trading prices, BIOS is priced at $10.80, while SSPK trades at $18.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SSPK's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SSPK's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to SSPK. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FCACU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FCACU has a market cap of 3.38B. Regarding current trading prices, BIOS is priced at $10.80, while FCACU trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FCACU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FCACU's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to FCACU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs CFVI Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CFVI has a market cap of 3.36B. Regarding current trading prices, BIOS is priced at $10.80, while CFVI trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CFVI's P/E ratio is -18.55. In terms of profitability, BIOS's ROE is +0.02%, compared to CFVI's ROE of -2.67%. Regarding short-term risk, BIOS is less volatile compared to CFVI. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs HOL Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, HOL has a market cap of 3.30B. Regarding current trading prices, BIOS is priced at $10.80, while HOL trades at $12.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas HOL's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to HOL's ROE of -0.13%. Regarding short-term risk, BIOS is less volatile compared to HOL. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs THCB Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, THCB has a market cap of 3.09B. Regarding current trading prices, BIOS is priced at $10.80, while THCB trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas THCB's P/E ratio is -81.30. In terms of profitability, BIOS's ROE is +0.02%, compared to THCB's ROE of +0.28%. Regarding short-term risk, BIOS is less volatile compared to THCB. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SOAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SOAC has a market cap of 2.82B. Regarding current trading prices, BIOS is priced at $10.80, while SOAC trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SOAC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SOAC's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to SOAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FUSE Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FUSE has a market cap of 2.79B. Regarding current trading prices, BIOS is priced at $10.80, while FUSE trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FUSE's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FUSE's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to FUSE. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DCRBU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DCRBU has a market cap of 2.78B. Regarding current trading prices, BIOS is priced at $10.80, while DCRBU trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DCRBU's P/E ratio is -16.00. In terms of profitability, BIOS's ROE is +0.02%, compared to DCRBU's ROE of -2.38%. Regarding short-term risk, BIOS is less volatile compared to DCRBU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs IVAN Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, IVAN has a market cap of 2.69B. Regarding current trading prices, BIOS is priced at $10.80, while IVAN trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas IVAN's P/E ratio is -698.18. In terms of profitability, BIOS's ROE is +0.02%, compared to IVAN's ROE of -0.33%. Regarding short-term risk, BIOS is less volatile compared to IVAN. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs GWAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, GWAC has a market cap of 2.60B. Regarding current trading prices, BIOS is priced at $10.80, while GWAC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas GWAC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to GWAC's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to GWAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs LCYAU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, LCYAU has a market cap of 2.56B. Regarding current trading prices, BIOS is priced at $10.80, while LCYAU trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas LCYAU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to LCYAU's ROE of +0.05%. Regarding short-term risk, BIOS is more volatile compared to LCYAU. This indicates potentially higher risk in terms of short-term price fluctuations for BIOS.
BIOS vs APXTU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, APXTU has a market cap of 2.54B. Regarding current trading prices, BIOS is priced at $10.80, while APXTU trades at $13.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas APXTU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to APXTU's ROE of -0.01%. Regarding short-term risk, BIOS is more volatile compared to APXTU. This indicates potentially higher risk in terms of short-term price fluctuations for BIOS.
BIOS vs FWAA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FWAA has a market cap of 2.40B. Regarding current trading prices, BIOS is priced at $10.80, while FWAA trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FWAA's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FWAA's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to FWAA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs GSAH Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, GSAH has a market cap of 2.38B. Regarding current trading prices, BIOS is priced at $10.80, while GSAH trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas GSAH's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to GSAH's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to GSAH. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs LCY Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, LCY has a market cap of 2.37B. Regarding current trading prices, BIOS is priced at $10.80, while LCY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas LCY's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to LCY's ROE of +0.05%. Regarding short-term risk, BIOS is less volatile compared to LCY. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FORE Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FORE has a market cap of 2.31B. Regarding current trading prices, BIOS is priced at $10.80, while FORE trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FORE's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FORE's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to FORE. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs APXT Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, APXT has a market cap of 2.26B. Regarding current trading prices, BIOS is priced at $10.80, while APXT trades at $12.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas APXT's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to APXT's ROE of -0.01%. Regarding short-term risk, BIOS is less volatile compared to APXT. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs RAAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, RAAC has a market cap of 2.20B. Regarding current trading prices, BIOS is priced at $10.80, while RAAC trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas RAAC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to RAAC's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to RAAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SPNV Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SPNV has a market cap of 2.18B. Regarding current trading prices, BIOS is priced at $10.80, while SPNV trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SPNV's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SPNV's ROE of -1.07%. Regarding short-term risk, BIOS is less volatile compared to SPNV. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DNAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DNAC has a market cap of 2.16B. Regarding current trading prices, BIOS is priced at $10.80, while DNAC trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DNAC's P/E ratio is -37.72. In terms of profitability, BIOS's ROE is +0.02%, compared to DNAC's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to DNAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FAII Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FAII has a market cap of 2.13B. Regarding current trading prices, BIOS is priced at $10.80, while FAII trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FAII's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FAII's ROE of -0.32%. Regarding short-term risk, BIOS is less volatile compared to FAII. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DMYI Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DMYI has a market cap of 2.08B. Regarding current trading prices, BIOS is priced at $10.80, while DMYI trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DMYI's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to DMYI's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to DMYI. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs LOKB Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, LOKB has a market cap of 2.05B. Regarding current trading prices, BIOS is priced at $10.80, while LOKB trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas LOKB's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to LOKB's ROE of -0.27%. Regarding short-term risk, BIOS is less volatile compared to LOKB. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs STPC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, STPC has a market cap of 2.04B. Regarding current trading prices, BIOS is priced at $10.80, while STPC trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas STPC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to STPC's ROE of -0.29%. Regarding short-term risk, BIOS is less volatile compared to STPC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs MUDS Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, MUDS has a market cap of 2.04B. Regarding current trading prices, BIOS is priced at $10.80, while MUDS trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas MUDS's P/E ratio is 3.39. In terms of profitability, BIOS's ROE is +0.02%, compared to MUDS's ROE of -0.01%. Regarding short-term risk, BIOS is less volatile compared to MUDS. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs MUDSU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, MUDSU has a market cap of 2.03B. Regarding current trading prices, BIOS is priced at $10.80, while MUDSU trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas MUDSU's P/E ratio is -1125.56. In terms of profitability, BIOS's ROE is +0.02%, compared to MUDSU's ROE of -0.01%. Regarding short-term risk, BIOS is more volatile compared to MUDSU. This indicates potentially higher risk in terms of short-term price fluctuations for BIOS.
BIOS vs TINV Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, TINV has a market cap of 2.02B. Regarding current trading prices, BIOS is priced at $10.80, while TINV trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas TINV's P/E ratio is 30.61. In terms of profitability, BIOS's ROE is +0.02%, compared to TINV's ROE of -2.84%. Regarding short-term risk, BIOS is less volatile compared to TINV. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs CMII Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CMII has a market cap of 1.99B. Regarding current trading prices, BIOS is priced at $10.80, while CMII trades at $10.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CMII's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to CMII's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to CMII. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DWAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DWAC has a market cap of 1.86B. Regarding current trading prices, BIOS is priced at $10.80, while DWAC trades at $49.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DWAC's P/E ratio is -73.46. In terms of profitability, BIOS's ROE is +0.02%, compared to DWAC's ROE of -0.58%. Regarding short-term risk, BIOS is less volatile compared to DWAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DWACU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DWACU has a market cap of 1.86B. Regarding current trading prices, BIOS is priced at $10.80, while DWACU trades at $61.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DWACU's P/E ratio is -451.10. In terms of profitability, BIOS's ROE is +0.02%, compared to DWACU's ROE of -0.58%. Regarding short-term risk, BIOS is less volatile compared to DWACU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs ATHN Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, ATHN has a market cap of 1.84B. Regarding current trading prices, BIOS is priced at $10.80, while ATHN trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas ATHN's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to ATHN's ROE of -4.14%. Regarding short-term risk, BIOS is less volatile compared to ATHN. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs GMII Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, GMII has a market cap of 1.83B. Regarding current trading prices, BIOS is priced at $10.80, while GMII trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas GMII's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to GMII's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to GMII. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SVACU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SVACU has a market cap of 1.78B. Regarding current trading prices, BIOS is priced at $10.80, while SVACU trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SVACU's P/E ratio is -22.89. In terms of profitability, BIOS's ROE is +0.02%, compared to SVACU's ROE of -0.04%. Regarding short-term risk, BIOS is less volatile compared to SVACU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs MOTV Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, MOTV has a market cap of 1.75B. Regarding current trading prices, BIOS is priced at $10.80, while MOTV trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas MOTV's P/E ratio is 55.86. In terms of profitability, BIOS's ROE is +0.02%, compared to MOTV's ROE of -0.17%. Regarding short-term risk, BIOS is less volatile compared to MOTV. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SVAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SVAC has a market cap of 1.72B. Regarding current trading prices, BIOS is priced at $10.80, while SVAC trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SVAC's P/E ratio is -32.05. In terms of profitability, BIOS's ROE is +0.02%, compared to SVAC's ROE of -0.04%. Regarding short-term risk, BIOS is less volatile compared to SVAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs CBAH Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CBAH has a market cap of 1.71B. Regarding current trading prices, BIOS is priced at $10.80, while CBAH trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CBAH's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to CBAH's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to CBAH. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs GXGXU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, GXGXU has a market cap of 1.69B. Regarding current trading prices, BIOS is priced at $10.80, while GXGXU trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas GXGXU's P/E ratio is -23.73. In terms of profitability, BIOS's ROE is +0.02%, compared to GXGXU's ROE of -0.01%. Regarding short-term risk, BIOS is less volatile compared to GXGXU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs AONE Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, AONE has a market cap of 1.67B. Regarding current trading prices, BIOS is priced at $10.80, while AONE trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas AONE's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to AONE's ROE of -0.06%. Regarding short-term risk, BIOS is less volatile compared to AONE. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SNPR Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SNPR has a market cap of 1.62B. Regarding current trading prices, BIOS is priced at $10.80, while SNPR trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SNPR's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SNPR's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to SNPR. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SPFR Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SPFR has a market cap of 1.58B. Regarding current trading prices, BIOS is priced at $10.80, while SPFR trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SPFR's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SPFR's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to SPFR. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DEH Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DEH has a market cap of 1.56B. Regarding current trading prices, BIOS is priced at $10.80, while DEH trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DEH's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to DEH's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to DEH. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs ROT Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, ROT has a market cap of 1.55B. Regarding current trading prices, BIOS is priced at $10.80, while ROT trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas ROT's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to ROT's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to ROT. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs NGAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, NGAC has a market cap of 1.48B. Regarding current trading prices, BIOS is priced at $10.80, while NGAC trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas NGAC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to NGAC's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to NGAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs GXGX Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, GXGX has a market cap of 1.48B. Regarding current trading prices, BIOS is priced at $10.80, while GXGX trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas GXGX's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to GXGX's ROE of -3.35%. Regarding short-term risk, BIOS is less volatile compared to GXGX. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs HECCU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, HECCU has a market cap of 1.43B. Regarding current trading prices, BIOS is priced at $10.80, while HECCU trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas HECCU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to HECCU's ROE of -0.06%. Regarding short-term risk, BIOS is less volatile compared to HECCU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs ATMR Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, ATMR has a market cap of 1.43B. Regarding current trading prices, BIOS is priced at $10.80, while ATMR trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas ATMR's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to ATMR's ROE of +0.04%. Regarding short-term risk, BIOS is less volatile compared to ATMR. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SFTW Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SFTW has a market cap of 1.38B. Regarding current trading prices, BIOS is priced at $10.80, while SFTW trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SFTW's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SFTW's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to SFTW. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs ENFA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, ENFA has a market cap of 1.34B. Regarding current trading prices, BIOS is priced at $10.80, while ENFA trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas ENFA's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to ENFA's ROE of -825.62%. Regarding short-term risk, BIOS is less volatile compared to ENFA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs ENVI Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, ENVI has a market cap of 1.34B. Regarding current trading prices, BIOS is priced at $10.80, while ENVI trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas ENVI's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to ENVI's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to ENVI. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DFNS Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DFNS has a market cap of 1.33B. Regarding current trading prices, BIOS is priced at $10.80, while DFNS trades at $12.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DFNS's P/E ratio is -17.39. In terms of profitability, BIOS's ROE is +0.02%, compared to DFNS's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to DFNS. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs ACTD Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, ACTD has a market cap of 1.32B. Regarding current trading prices, BIOS is priced at $10.80, while ACTD trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas ACTD's P/E ratio is -25.50. In terms of profitability, BIOS's ROE is +0.02%, compared to ACTD's ROE of +0.69%. Regarding short-term risk, BIOS is less volatile compared to ACTD. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs VCKA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, VCKA has a market cap of 1.31B. Regarding current trading prices, BIOS is priced at $10.80, while VCKA trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas VCKA's P/E ratio is 100.11. In terms of profitability, BIOS's ROE is +0.02%, compared to VCKA's ROE of +0.36%. Regarding short-term risk, BIOS is less volatile compared to VCKA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs THMA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, THMA has a market cap of 1.30B. Regarding current trading prices, BIOS is priced at $10.80, while THMA trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas THMA's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to THMA's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to THMA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs LNFA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, LNFA has a market cap of 1.29B. Regarding current trading prices, BIOS is priced at $10.80, while LNFA trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas LNFA's P/E ratio is 21.06. In terms of profitability, BIOS's ROE is +0.02%, compared to LNFA's ROE of +0.09%. Regarding short-term risk, BIOS is less volatile compared to LNFA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FTIVU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FTIVU has a market cap of 1.27B. Regarding current trading prices, BIOS is priced at $10.80, while FTIVU trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FTIVU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FTIVU's ROE of -0.41%. Regarding short-term risk, BIOS is less volatile compared to FTIVU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs STWO Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, STWO has a market cap of 1.27B. Regarding current trading prices, BIOS is priced at $10.80, while STWO trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas STWO's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to STWO's ROE of -1.47%. Regarding short-term risk, BIOS is less volatile compared to STWO. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs HYACU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, HYACU has a market cap of 1.21B. Regarding current trading prices, BIOS is priced at $10.80, while HYACU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas HYACU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to HYACU's ROE of +0.23%. Regarding short-term risk, BIOS is less volatile compared to HYACU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FTIV Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FTIV has a market cap of 1.20B. Regarding current trading prices, BIOS is priced at $10.80, while FTIV trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FTIV's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FTIV's ROE of -0.41%. Regarding short-term risk, BIOS is less volatile compared to FTIV. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs AHAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, AHAC has a market cap of 1.13B. Regarding current trading prices, BIOS is priced at $10.80, while AHAC trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas AHAC's P/E ratio is -72.11. In terms of profitability, BIOS's ROE is +0.02%, compared to AHAC's ROE of +5.02%. Regarding short-term risk, BIOS is less volatile compared to AHAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs AMHC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, AMHC has a market cap of 1.12B. Regarding current trading prices, BIOS is priced at $10.80, while AMHC trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas AMHC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to AMHC's ROE of -0.01%. Regarding short-term risk, BIOS is less volatile compared to AMHC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs HERA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, HERA has a market cap of 1.11B. Regarding current trading prices, BIOS is priced at $10.80, while HERA trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas HERA's P/E ratio is 46.32. In terms of profitability, BIOS's ROE is +0.02%, compared to HERA's ROE of +0.01%. Regarding short-term risk, BIOS is less volatile compared to HERA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs HERAW Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, HERAW has a market cap of 1.11B. Regarding current trading prices, BIOS is priced at $10.80, while HERAW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas HERAW's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to HERAW's ROE of +0.01%. Regarding short-term risk, BIOS is less volatile compared to HERAW. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FGNA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FGNA has a market cap of 1.10B. Regarding current trading prices, BIOS is priced at $10.80, while FGNA trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FGNA's P/E ratio is -4.35. In terms of profitability, BIOS's ROE is +0.02%, compared to FGNA's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to FGNA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs DNAA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, DNAA has a market cap of 1.10B. Regarding current trading prices, BIOS is priced at $10.80, while DNAA trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas DNAA's P/E ratio is -54.53. In terms of profitability, BIOS's ROE is +0.02%, compared to DNAA's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to DNAA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs RACA Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, RACA has a market cap of 1.09B. Regarding current trading prices, BIOS is priced at $10.80, while RACA trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas RACA's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to RACA's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to RACA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs TREB Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, TREB has a market cap of 1.07B. Regarding current trading prices, BIOS is priced at $10.80, while TREB trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas TREB's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to TREB's ROE of -0.00%. Regarding short-term risk, BIOS is less volatile compared to TREB. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs PACE Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, PACE has a market cap of 1.07B. Regarding current trading prices, BIOS is priced at $10.80, while PACE trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas PACE's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to PACE's ROE of -1.08%. Regarding short-term risk, BIOS is less volatile compared to PACE. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs HERAU Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, HERAU has a market cap of 1.06B. Regarding current trading prices, BIOS is priced at $10.80, while HERAU trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas HERAU's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to HERAU's ROE of +0.01%. Regarding short-term risk, BIOS is less volatile compared to HERAU. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs LSAQ Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, LSAQ has a market cap of 1.05B. Regarding current trading prices, BIOS is priced at $10.80, while LSAQ trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas LSAQ's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to LSAQ's ROE of N/A. Regarding short-term risk, BIOS is less volatile compared to LSAQ. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs SRAC Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SRAC has a market cap of 1.03B. Regarding current trading prices, BIOS is priced at $10.80, while SRAC trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SRAC's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SRAC's ROE of -0.02%. Regarding short-term risk, BIOS is less volatile compared to SRAC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs FTPAW Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, FTPAW has a market cap of 1.03B. Regarding current trading prices, BIOS is priced at $10.80, while FTPAW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas FTPAW's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to FTPAW's ROE of -0.00%. Regarding short-term risk, BIOS is more volatile compared to FTPAW. This indicates potentially higher risk in terms of short-term price fluctuations for BIOS.
BIOS vs SBG Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, SBG has a market cap of 1.02B. Regarding current trading prices, BIOS is priced at $10.80, while SBG trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas SBG's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to SBG's ROE of -3.85%. Regarding short-term risk, BIOS is less volatile compared to SBG. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.
BIOS vs CVII-WT Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CVII-WT has a market cap of 977.91M. Regarding current trading prices, BIOS is priced at $10.80, while CVII-WT trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CVII-WT's P/E ratio is N/A. In terms of profitability, BIOS's ROE is +0.02%, compared to CVII-WT's ROE of +0.00%. Regarding short-term risk, BIOS is more volatile compared to CVII-WT. This indicates potentially higher risk in terms of short-term price fluctuations for BIOS.
BIOS vs CVII-UN Comparison
BIOS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOS stands at 209.07M. In comparison, CVII-UN has a market cap of 958.85M. Regarding current trading prices, BIOS is priced at $10.80, while CVII-UN trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOS currently has a P/E ratio of 51.40, whereas CVII-UN's P/E ratio is 64.65. In terms of profitability, BIOS's ROE is +0.02%, compared to CVII-UN's ROE of +0.00%. Regarding short-term risk, BIOS is less volatile compared to CVII-UN. This indicates potentially lower risk in terms of short-term price fluctuations for BIOS.